| Title |
A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease
|
|---|---|
| Published in |
Neurology, April 2012
|
| DOI | 10.1212/wnl.0b013e3182516244 |
| Pubmed ID | |
| Authors |
I.H. Richard, M.P. McDermott, R. Kurlan, J.M. Lyness, P.G. Como, N. Pearson, S.A. Factor, J. Juncos, C. Serrano Ramos, M. Brodsky, C. Manning, L. Marsh, L. Shulman, H.H. Fernandez, K.J. Black, M. Panisset, C.W. Christine, W. Jiang, C. Singer, S. Horn, R. Pfeiffer, D. Rottenberg, J. Slevin, L. Elmer, D. Press, H.C. Hyson, W. McDonald, Irene Richard, William McDonald, Michael McDermott, Peter G. Como, Roger Kurlan, Jeffrey M. Lyness, Nancy Pearson, Barbara Sommerfeld, Cheryl Deeley, Tania de la Torre, Michele Barnard, April Wilson, Maryann Lincoln, Paula Damgaard, Melissa Gerstenhaber, Kelly Dustin, Nancy Zappala, Camille Swartz, Mary Creech, Elda Shipley, Samantha Blankenship, Monica Beland, Jessie Roth, Heather Burnette, Tamara Foxworth, Monica Quesada, Mary Lloyd, Brenda Pfeiffer, Joy Hansen, Joy Folie, Renee Wagner, Julia Spears, Colleen Taylor, Rachel Brown, Lisa Iguchi, Chen Lim, Kori LaDonna, Julie Megens, Matthew Menza, Jeffrey Cummings, Robert Hamer, Kathleen Shannon, Joanne Odenkirchen, Robin Conwit, Christopher Beck, Donna LaDonna, Jan Bausch, Scott Kim, Ron Chismar, Sinead Quinn, Steve Bean, Susan Daigneault, Patricia Lindsay, Tori Ross, Katie Kompoliti |
| Abstract |
To evaluate the efficacy and safety of a selective serotonin reuptake inhibitor (SSRI) and a serotonin and norepinephrine reuptake inhibitor (SNRI) in the treatment of depression in Parkinson disease (PD). |
Login to access the Attention Digest and the Sentiment Analysis related to this output.
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 6 | 29% |
| United Kingdom | 2 | 10% |
| Peru | 1 | 5% |
| Russia | 1 | 5% |
| Brazil | 1 | 5% |
| Italy | 1 | 5% |
| Turkey | 1 | 5% |
| Comoros | 1 | 5% |
| Unknown | 7 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 17 | 81% |
| Practitioners (doctors, other healthcare professionals) | 4 | 19% |
Mendeley demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | <1% |
| United Kingdom | 2 | <1% |
| Switzerland | 2 | <1% |
| Canada | 2 | <1% |
| Unknown | 235 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 34 | 14% |
| Student > Master | 31 | 13% |
| Student > Ph. D. Student | 23 | 9% |
| Other | 19 | 8% |
| Student > Bachelor | 19 | 8% |
| Other | 56 | 23% |
| Unknown | 61 | 25% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 80 | 33% |
| Neuroscience | 28 | 12% |
| Psychology | 14 | 6% |
| Agricultural and Biological Sciences | 11 | 5% |
| Nursing and Health Professions | 10 | 4% |
| Other | 30 | 12% |
| Unknown | 70 | 29% |